Other studies suggest that berberine may have an impact on factors such as waist-to-hip ratio and fat distribution, which are associated with overall health
For patients with chronic kidney disease or heart failure, SGLT2 inhibitors are generally prioritised, with GLP-1 receptor agonists as complementary therapy where appropriate
Key metabolic hormones (including glucagon-like peptide-1 (GLP-1), leptin, ghrelin, and cholecystokinin (CCK) play dual roles: not only regulating hunger and metabolism, but also directly modulating the activity and expression of taste receptors throughout the oral cavity and gastrointestinal tract
This is a supplement worth discussing with your provider before starting, and taken for 3 months max at a time
Dual strategies that address both metabolic disorders and depression simultaneously appear reasonable
GIP/GLP-1 agonists, like Zepbound (tirzepatide), are prescription medications that have had a massive surge in popularity over the past years